Arrhythmias & electrophysiology

Gastroesophageal Reflux Disease and Risk of Atrial Fibrillation/Flutter: Implications for Heart Failure Progression

ESC Heart FailPublished bidirectional two-sample Mendelian randomization (MR) analysis

Main finding · AF/AFL risk (causal effect of GERD; IVW, primary analytical method)Result — go to the resultOdds ratio 1.373 95% CI 1.208–1.600

Authors' conclusion

Genetic liability to GERD independently increases AF/AFL risk, unaffected by obesity pathways. Considering the well-established role of AF/AFL in the pathogenesis and progression of HF, our findings position GERD as a potential modifiable target within the causal pathway. Identification and management of GERD may therefore contribute to reducing atrial arrhythmia burden and subsequent HF risk.

Study context

Population
European populations (genome-wide association study (GWAS) summary data)Gastroesophageal reflux disease (GERD) cases 129,080 · GERD controls 473,524 · AF/AFL cases 22,068 · AF/AFL controls 116,926 · Obesity cases 4,793 · Obesity controls 209,884
Comparison
Bidirectional causal relationships
Outcome
AF/AFL risk (causal effect of GERD; IVW, primary analytical method)
Methodological detailsMultivariable MR (MVMR) adjusted for obesity
  • Multivariable MR (MVMR) adjusted for obesity

Main finding

As reported in the abstract

Odds ratio

1.373

95% CI 1.208–1.600

P = 0.017

GERD
OR 1.373 (95% CI 1.208–1.600); P = 0.017

Further findings

AF/AFL risk after MVMR adjustment for obesity

ComparisonOR (95% CI)P value
GERDMVMR adjusted for obesity1.303 (1.127–1.507)P < 0.001

Reverse causality

Two-way analysis indicated no reverse causality

Sensitivity analyses

Sensitivity analyses supported result robustness with minimal pleiotropy

Original publication

Gastroesophageal Reflux Disease and Risk of Atrial Fibrillation/Flutter: Implications for Heart Failure Progression. ESC Heart Fail. Published 9 November 2025. doi:10.1002/ehf2.70009

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.